.jpg)
本公司成立於2021年4月，聖安生醫擁有多項新穎的專利和抗體技術平台，集結國內外多位專業博碩士研發團隊及醫事背景的顧問群，以病人最佳癌症治療策略為核心，致力於新穎有效的多特異性抗體藥物與核酸治療藥物開發。
AboutAbout Shine-OnRead More
NewsNews CenterRead More
-
The Ministry of Health and Welfare continues to promote the "three methods of regenerative medicine" and expands organelles, seeking review by the Executive Yuan in Q2
The Ministry of Health and Welfare continues to promote the "three methods of regenerative medicine" and expands organelles, seeking review by the Executive Yuan in Q2 -
Latest U.S. FDA regulations: human gene therapy to treat rare diseases
Latest U.S. FDA regulations: human gene therapy to treat rare diseases -
The latest U.S. FDA regulations: Chemical manufacturing controls for human gene therapy new drug clinical trial applications
The latest U.S. FDA regulations: Chemical manufacturing controls for human gene therapy new drug clinical trial applications
LinksFavorite LinksRead More
